Larotrectinib Sulfate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Larotrectinib Sulfate
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Larotrectinib Sulfate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 2 USDMF, 4 NDC API, 3 Listed Suppliers, $ API Reference Price

7 API Suppliers
2 USDMF
4 NDC API
3 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 3 FDA Orange Book

3 FDF Dossiers
3 FDA Orange Book

DIGITAL CONTENT

1 News #PharmaBuzz

1 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

48 US Patents, 9 US Exclusivities, 7 Health Canada Patents

48 US Patents
9 US Exclusivities
7 Health Canada Patents

$ API Ref.Price (USD/KG) : 29,765 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Bayer Inc.

filter Patent Reset all filters

7 All

01 32741313

02 32967951

03 13019671

filter Product Reset all filters

7 All

01 7LAROTRECTINIB SULFATE

filter Dosage Reset all filters

7 All

01 4CAPSULE

02 3SOLUTION

filter Exp Date Reset all filters

7 All

01 32029-10-21

02 32035-11-16

03 12037-04-04

Product Main Page

01

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-21

Date Granted : 2018-12-04

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 2741313

Filing Date : 2009-10-21

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-10-21

Date Granted : 2018-12-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-21

Date Granted : 2018-12-04

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 2741313

Filing Date : 2009-10-21

Strength per Unit : 25 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-10-21

Date Granted : 2018-12-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-21

Date Granted : 2018-12-04

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 2741313

Filing Date : 2009-10-21

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-10-21

Date Granted : 2018-12-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-16

Date Granted : 2023-11-07

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 2967951

Filing Date : 2015-11-16

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-11-16

Date Granted : 2023-11-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-04

Date Granted : 2024-02-20

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 3019671

Filing Date : 2017-04-04

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-04-04

Date Granted : 2024-02-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-16

Date Granted : 2023-11-07

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 2967951

Filing Date : 2015-11-16

Strength per Unit : 25 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-11-16

Date Granted : 2023-11-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Bayer Inc.

Larotrectinib Sulfate

CPHI Shenzhen

Not Confirmed

Bayer Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-16

Date Granted : 2023-11-07

Larotrectinib Sulfate

Brand Name : VITRAKVI

Patent Number : 2967951

Filing Date : 2015-11-16

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-11-16

Date Granted : 2023-11-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!